Skip to main content
Smart Investors Daily
Humana Inc. logo

NYSE · HUM

Humana Inc.

Healthcare · Medical - Healthcare Plans

$385.78

Down-$5.78 (-1.50%)

Updated Nov 20, 2026, 1:56 AM

SID Score

6.8/10

Composite research score

Smart Money

58/100

Neutral

Market cap
32B
P/E ratio
24.85
Dividend yield
1.15%
52-week range
$163.11 – $462.87
Volume
4.16M
Avg. volume
1.8M

Price performance · HUM

HUM price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 18, 2026

HUM closed at $385.78 after 20 trading sessions, down 8.36% for the selected period.

Last close
$385.78
Period change
-8.36%
Period low
$385.78
Period high
$461.25
Daily close
View OHLC price history
HUM OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 18, 2026$441.44$443.52$384.61$385.784.16M
Nov 17, 2026$447.00$447.00$431.78$443.341.89M
Nov 16, 2026$460.00$462.869$449.08$461.251.31M
Nov 13, 2026$445.69$451.04$435.39$450.001.5M
Nov 12, 2026$450.00$450.00$434.09$443.681.94M
Nov 11, 2026$443.02$451.00$439.23$446.312.5M
Nov 10, 2026$425.36$443.03$422.63$438.062.11M
Nov 9, 2026$438.57$448.44$422.33$423.222.45M
Nov 6, 2026$415.00$444.00$411.555$433.742.58M
Nov 5, 2026$417.47$423.965$405.40$411.791.36M
Nov 4, 2026$414.38$427.065$404.18$417.421.86M
Nov 3, 2026$407.87$422.65$405.45$417.871.37M
Nov 2, 2026$420.64$420.64$399.35$410.41917.99K
Oct 30, 2026$415.66$420.35$409.44$414.50887.97K
Oct 29, 2026$416.11$418.56$408.79$417.561.02M
Oct 28, 2026$416.00$421.95$410.95$411.871.05M
Oct 27, 2026$416.66$420.025$411.58$414.85697.31K
Oct 26, 2026$426.27$430.15$415.26$417.221.3M
Oct 23, 2026$420.60$425.925$417.00$422.071.2M
Oct 22, 2026$423.16$428.305$417.49$420.971.81M

Latest HUM news

The latest Smart Investors Daily articles mentioning HUM.

HUM research

Overview

Company profile and research snapshot.

Company profile

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$293.17
Implied upside
—
Analysts
—
HUM recent ratings
DateFirmRatingTarget
Nov 12, 2026Wells FargoOverweight—
Nov 11, 2026TD CowenHold—
Nov 10, 2026JP MorganNeutral—
Nov 9, 2026Cantor FitzgeraldOverweight—
Nov 9, 2026BarclaysOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 12, 2026

As AI Outpaces Companies’ Ability to Manage It, Axway Gives Enterprises Control of What Their AI Does and What It Costs

SCOTTSDALE, Ariz., November 12, 2026--Enterprises are racing to put AI to work, but many still can't account for what it costs or how it uses company data to make decisions across disparate systems. Today Axway, a 74Software company (Euronext: 74SW) trusted by more than 4,000 organizations, introduced Amplify Platform to close that gap. The platform gives enterprises, including those in highly regulated industries, a foundation to securely connect, govern and orchestrate the APIs, integrations,

Yahoo · Nov 11, 2026

Humana (HUM) Stock Gets Fair Value Bump After Star Ratings And Q3 Beat

The latest valuation work on Humana lifts the assessed fair value from US$465.13 to US$475.54, signaling a modest reset in price targets. Analysts linking this move to recent Q3 results and improved Medicare Advantage Star Ratings describe a generally constructive mood, even as some still flag policy and execution risks. Read on to see what is driving the shifting Humana story and how you can track the next turns in this narrative. Analyst Price Targets don't always capture the full story...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.